Demonstrates the changing relationship between ESG activities and firm value across life cycle stages, suggesting implications for policy development.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ji-Hye Kim (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: